What cancer care can learn from the NFL

Superbowl Sunday, basically a holiday in the U.S., could teach us more than how to tackle the quarterback. In an article by Forbes, Kathy Giusti and Richard G. Hamermesh, Founder of the Multiple Myeloma Research Foundation, and Senior Fellow at Harvard Business School, explain what precision medicine can learn from the NFL.

Integrating itself into many American families, the NFL is a major part of their lives. Every year the NFL showcases how rivals face each other and battle to the top, a quality the field of cancer care and research lack. Giusti and Hamermesh review how the NFL factors of joined sponsor activities, a culture of shared values and competition can make a big impact on cancer care.

Read the full story below: 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology? 

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.